Clinical Trials
8 trialsNCT02942758 2024-05-08
AML-ViVA
University Hospital Regensburg
Phase 2 Terminated
NCT00203996 2023-03-21
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
University of Chicago
Phase 4 Terminated
NCT02730195 2019-01-09
Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
Emory University
Phase 2 Terminated
NCT00867126 2018-11-26
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT01342770 2017-12-05
Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00868140 2016-06-10
PCOS
Virginia Commonwealth University
Phase NA Terminated
NCT00951379 2016-04-06
Pioglitazone for Oral Premalignant Lesions
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00923949 2015-09-30
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated